ARWR

#942
Arrowhead Research Corporation
67.1500 USD
+5.27%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
66.2500
67.2250
Rango anual
37.0600
76.7600
Cambio diario
+5.27%
Variación mensual
+19.91%
Variación en los últimos 6 meses
+71.74%
Cambio anual
+71.74%
Cierres anteriores
63.7900
Abrir
66.2900
Bid
Ask
Mínimo
66.2500
High
67.2250
Volumen
216
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 9.4032 B
  • Employee 711
  • Founded 2004
  • CEO Christopher Richard Anzalone
  • Website www.arrowheadpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRVKH0
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3 449
Relación precio/flujo de caja
5.56

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Noticias